Literature DB >> 28488045

[Musculoskeletal manifestations of sarcoidosis].

P Korsten1, G Chehab2.   

Abstract

Musculoskeletal manifestations in the context of sarcoidosis are frequently observed. The rheumatologist regularly encounters this disease in clinical practice. In the present review, we aim to give a current overview of the manifestations and treatments relevant to the practicing rheumatologist. The most frequently encountered manifestation is Lofgren's syndrome, which is characterized by bilateral ankle periarthritis, bilateral hilar lymphadenopathy, and erythema nodosum and has an excellent prognosis. Chronic arthropathy most commonly manifests as oligoarthritis, which sometimes hampers its differentiation from spondylarthropathies, especially when sacroiliitis, enthesitis or dactylitis are simultaneously present. Isolated vertebral granulomas are rare and require infectious and malignant disorders to be excluded, since there are no specific imaging findings that are exclusively found in vertebral sarcoidosis. The presence of granulomas in skeletal muscle is common in muscle biopsies, whereas clinically overt myopathy is present in only around 1-2% of patients. Therapeutic responses vary among the different clinical phenotypes. Non-steroidal anti-inflammatory drugs and low to medium dose glucocorticoids are the first-line therapy for musculoskeletal manifestations and often lead to adequate disease control in acute sarcoidosis. When these are ineffective or not tolerated, steroid-sparing agents are increasingly used in chronic sarcoidosis. Evidence for all medications used in sarcoid-related arthritis is comparatively scant. When supplementing vitamin D, the possible development of hypercalcemia, even at standard doses, needs to be considered; the optimal therapeutic levels for the prevention of medication-induced osteoporosis in sarcoidosis have not been firmly established.

Entities:  

Keywords:  Arthritis; Biologic agents; Immunosuppressants; Musculoskeletal diseases; Myopathic conditions

Mesh:

Substances:

Year:  2017        PMID: 28488045     DOI: 10.1007/s00393-017-0313-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  54 in total

1.  Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis.

Authors:  M W Ziegenhagen; M E Rothe; M Schlaak; J Müller-Quernheim
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

2.  Is Sarcoid Dactylitis Worse Than We ExPEcT?

Authors:  Julien Matuszak; Jean Durckel; Jean Sibilia; Dan Lipsker; Cyrille Blondet; Alessio Imperiale
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

3.  Ultrasound findings in Löfgren's syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis?

Authors:  H Kellner; S Späthling; P Herzer
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

4.  An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis.

Authors:  Nicola Erb; Michael J Cushley; Dimitrios G Kassimos; Ruth M Shave; George D Kitas
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

5.  Seasonal variation in incidence of sarcoidosis: a population-based study, 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Thorax       Date:  2016-08-18       Impact factor: 9.139

Review 6.  Acute sarcoid myositis with respiratory muscle involvement. Case report and review of the literature.

Authors:  D Ost; A Yeldandi; D Cugell
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

Review 7.  Myopathy in sarcoidosis: clinical and pathologic study of four cases and review of the literature.

Authors:  S M Wolfe; R S Pinals; J A Aelion; R E Goodman
Journal:  Semin Arthritis Rheum       Date:  1987-05       Impact factor: 5.532

8.  Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-05       Impact factor: 4.794

Review 9.  Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature.

Authors:  J T Gran; E Bøhmer
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

10.  The prevalence of sacroiliitis and spondyloarthritis in patients with sarcoidosis.

Authors:  Senol Kobak; Fidan Sever; Ozlem Ince; Mehmet Orman
Journal:  Int J Rheumatol       Date:  2014-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.